An Observational Study to Estimate Incidence Rates of Heart Failure Among US Racial and Ethnic Minority Patients With Multiple Myeloma Treated or Not Treated With Carfilzomib

First published 10/08/2019

Last updated 09/12/2020

EU PAS number:

EUPAS30748

Study

Finalised

Documents

Study protocol

Initial protocol

20190012_Public Redacted Protocol Amend 1 English

English (846.34 KB - PDF)View document

Study results

20190012_ Observational Research Study Report Published Report

English (9.41 MB - PDF)View document

Study report

Other information

ENCePP Seal

ENCePP Seal documents

Secondary tabs